Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019
Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism? Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Prevalance and characteristics of overlap syndrome in patients with obstructive sleep apnea Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002
Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism Source: Sleep and Breathing Conference 2021 Year: 2021
The evaluation of risk of obstructive sleep apnea syndrome in individuals with dysglycaemia Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
Characteristics of Italian patients with obstructive sleep apnea syndrome (OSAS) and gender differences Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
The analysis of sleep questionnaire of patients who diagnosed obstructive sleep apnea syndrome in the university hospital Source: Eur Respir J 2005; 26: Suppl. 49, 117s Year: 2005
Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006
Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006
Biochemical basis of inflammation in children with obstructive sleep apnea syndrome (OSAS) and in children with obesity Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Analysis of HLA in Korean patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 214s Year: 2002
Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002
Differences in obstructive sleep apnea syndrome (OSA) according to gender in patients with suspected OSA Source: International Congress 2017 – Variation in th phenotypes and symptoms of obstructive sleep apnoea Year: 2017
Prevalence of obstructive sleep apnoea syndrome among patients of general hospital: epidemiological study Source: Eur Respir J 2001; 18: Suppl. 33, 256s Year: 2001